اختلال پایدار پروتئین‌های سرم و ایمونوگلوبولین‌ها در مرحله پس از حاد کووید-۱۹: یک مطالعه کوهورت آینده‌نگر

P. A. Leggat, J. Frean and L. Blumberg. COVID-19: Current Challenges and Future Perspectives. Trop Med Infect Dis 2022;7. doi: 10.3390/tropicalmed7020016

M. Rohani-Rasaf, F. Ghavidel, H. Hosseini and M. Teimouri. The predictive significance of uric acid to high density lipoprotein- cholesterol ratio and uric acid for the severity and mortality of coronavirus disease-19. BMC Research Notes 2024;17:277. doi: 10.1186/s13104-024-06807-7

H. Hosseini, M. Rohani-Rasaf, A. Vatannejad, M. Shabani and M. Teimouri. Assessment of Leukocyte Subtypes to High-Density Lipoprotein-Cholesterol (HDL-C) Ratios as predictors of Severity and Mortality in COVID-19 Patients. Acta Biochimica Iranica 2023. doi:

J. Torres-Ruiz, et al. Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study. Infect Dis (Lond) 2023;55:243-54. doi: 10.1080/23744235.2022.2158217

J. R. Ulloque-Badaracco, M. D. Mosquera-Rojas, E. A. Hernandez-Bustamante, E. A. Alarcón-Braga, P. Herrera-Añazco and V. A. Benites-Zapata. Prognostic value of albumin-to-globulin ratio in COVID-19 patients: A systematic review and meta-analysis. Heliyon 2022;8:e09457. doi: 10.1016/j.heliyon.2022.e09457

I. Arnau-Barrés, et al. Severe Hypoalbuminemia at Admission Is Strongly Associated with Worse Prognosis in Older Adults with SARS-CoV-2 Infection. J Clin Med 2021;10. doi: 10.3390/jcm10215134

R. de la Rica, et al. Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study. Microorganisms 2020;8. doi: 10.3390/microorganisms8081106

M. C. Viana-Llamas, et al. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Engl Ed) 2021;156:428-36. doi: 10.1016/j.medcle.2020.12.015

A. Eckart, et al. Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study. Am J Med 2020;133:713-22.e7. doi: 10.1016/j.amjmed.2019.10.031

D. A. Belinskaia, P. A. Voronina and N. V. Goncharov. Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological Aspects. J Evol Biochem Physiol 2021;57:1419-48. doi: 10.1134/s002209302106020x

F. Ceciliani, A. Giordano and V. Spagnolo. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 2002;9:211-23. doi: 10.2174/0929866023408779

A. L. Silva-Junior, et al. Immunologic mediators profile in COVID-19 convalescence. Sci Rep 2024;14:20930. doi: 10.1038/s41598-024-71419-x

W. Zhou, et al. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19. J Med Virol 2021;93:924-33. doi: 10.1002/jmv.26353

M. Al-Tamimi, et al. Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals. PLoS One 2023;18:e0281689. doi: 10.1371/journal.pone.0281689

N. Kopplin, et al. Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort. Plos one 2023;18:e0291259. doi:

F. Violi, et al. Is Albumin Predictor of Mortality in COVID-19? Antioxid Redox Signal 2021;35:139-42. doi: 10.1089/ars.2020.8142

F. Zhou, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. doi: 10.1016/s0140-6736(20)30566-3

N. P. Somasundaram, et al. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System. J Endocr Soc 2020;4:bvaa082. doi: 10.1210/jendso/bvaa082

K. M. Ali, A. M. Ali, H. M. Tawfeeq, G. P. Figueredo and H. M. Rostam. Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019. J Med Virol 2021;93:4532-6. doi: 10.1002/jmv.27002

D. C. di Flora, et al. Analysis of Plasma Proteins Involved in Inflammation, Immune Response/Complement System, and Blood Coagulation upon Admission of COVID-19 Patients to Hospital May Help to Predict the Prognosis of the Disease. Cells 2023;12. doi: 10.3390/cells12121601

J. Vandooren and Y. Itoh. Alpha-2-macroglobulin in inflammation, immunity and infections. Frontiers in immunology 2021;12:803244. doi:

S. Pushalkar, et al. Complex changes in serum protein levels in COVID-19 convalescents. Sci Rep 2024;14:4479. doi: 10.1038/s41598-024-54534-7

C. P. Argyropoulos, S. S. Chen, Y. H. Ng, M. E. Roumelioti, K. Shaffi, P. P. Singh and A. H. Tzamaloukas. Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Front Med (Lausanne) 2017;4:73. doi: 10.3389/fmed.2017.00073

Y. Fukao, et al. COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine. Clin Exp Nephrol 2021;25:1240-6. doi: 10.1007/s10157-021-02101-z

W. Conca, et al. Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity? PLoS One 2021;16:e0247758. doi: 10.1371/journal.pone.0247758

S. Gong, R. Ma, T. Zhu, X. Ge, R. Xie, Q. Tao and C. Shi. Elevated serum beta-2 microglobulin level predicts short-term poor prognosis of patients with de novo acute omicron variant COVID-19 infection. Front Cell Infect Microbiol 2023;13:1204326. doi: 10.3389/fcimb.2023.1204326

Q.-X. Long, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine 2020;26:845-8. doi: 10.1038/s41591-020-0897-1

C. Lucas, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 2020;584:463-9. doi: 10.1038/s41586-020-2588-y

R. R. Goel, et al. Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination. Sci Immunol 2021;6. doi: 10.1126/sciimmunol.abi6950